Analyst firms · Oppenheimer · ORCL

Oppenheimer ORCL price target and rating history

Oracle Corporation (ORCL) · Technology

Oppenheimer rates Oracle Corporation (ORCL) Outperform with a $235 price target, as of its latest action on May 12, 2026. It has published 4 rating actions on ORCL since April 2024, including 1 upgrade and 0 downgrades. Across 10 firms with a ORCL price target in the last 12 months, the median target is $219. Oppenheimer's $235 is 7% above that.

Current rating
Outperform
Price target
$235
Median target, all firms
$219
Actions on ORCL
4

Oppenheimer price target on ORCL

$235$210$185
Oppenheimer price target on ORCL, each point a stated target, February 2026 to May 2026.

Every Oppenheimer rating on ORCL

How other firms rate ORCL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StephensOverweight$213Nov 2, 2026
BMO Capital MarketsOutperform$195Sep 11, 2026
CLSAHold$145Jul 20, 2026
OppenheimerOutperform$235May 12, 2026
Arete ResearchBuy$255May 7, 2026
WedbushOutperform$225Apr 24, 2026
Cleveland ResearchNeutralApr 10, 2026
BofA SecuritiesBuy$200Mar 24, 2026
MeliusHoldFeb 9, 2026
DA DavidsonBuy$180Feb 9, 2026
Goldman SachsBuy$240Jan 12, 2026
Wells FargoOverweight$280Dec 3, 2025
Erste GroupHoldNov 10, 2025

Questions about Oppenheimer and ORCL

What is Oppenheimer's price target for ORCL?
Oppenheimer's latest stated price target for Oracle Corporation (ORCL) is $235, from its action on May 12, 2026.
What is Oppenheimer's rating on ORCL?
Oppenheimer rates ORCL Outperform, a bullish rating, as of May 12, 2026.
When did Oppenheimer last change its view on ORCL?
On May 12, 2026, Oppenheimer raises its price target to $235 from $210, keeps Outperform.
How does Oppenheimer's ORCL target compare with other analysts?
Across 10 firms with a ORCL price target in the last 12 months, the median target is $219. Oppenheimer's $235 is 7% above that.

More ORCL rating histories

All Oppenheimer ratingsORCL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.